First Time Loading...

IDT Australia Ltd
ASX:IDT

Watchlist Manager
IDT Australia Ltd Logo
IDT Australia Ltd
ASX:IDT
Watchlist
Price: 0.091 AUD -4.21% Market Closed
Updated: May 3, 2024

Wall Street
Price Targets

IDT Price Targets Summary
IDT Australia Ltd

Wall Street analysts forecast IDT stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDT is 0.08 AUD .

Lowest
Price Target
Not Available
Average
Price Target
0.08 AUD
12% Downside
Highest
Price Target
Not Available
IDT Australia Ltd Competitors:
Price Targets
600594
Guizhou Yibai Pharmaceutical Co Ltd
57% Upside
DRREDDY
Dr Reddy's Laboratories Ltd
5% Downside
ATAI
ATAI Life Sciences NV
412% Upside
AHEALTH
Apex Healthcare Bhd
21% Downside
PAHC
Phibro Animal Health Corp
35% Downside
1795
Lotus Pharmaceutical Co Ltd
39% Upside
SUPRIYA
Supriya Lifescience Ltd
2% Upside
LAURUSLABS
Laurus Labs Ltd
15% Downside

Revenue
Forecast

Revenue Estimate
IDT Australia Ltd

For the last 8 years the compound annual growth rate for IDT Australia Ltd's revenue is -10%. The projected CAGR for the next 3 years is 56%.

-10%
Past Growth
56%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
IDT Australia Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
IDT Australia Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDT's stock price target?
Price Target
0.08 AUD

According to Wall Street analysts, the average 1-year price target for IDT is 0.08 AUD .

What is IDT Australia Ltd's Revenue forecast?
Projected CAGR
56%

For the last 8 years the compound annual growth rate for IDT Australia Ltd's revenue is -10%. The projected CAGR for the next 3 years is 56%.